Skip to content

Carbetocin for the reduction of blood loss during myomectomy

Tranexamic Acid versus Carbetocin for Reduction of Blood loss during Abdominal Myomectomy

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
PACTR
Registry ID
PACTR201908793583382
Enrollment
132
Registered
2019-08-06
Start date
2016-05-01
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

myomectomy surgery

Interventions

Sponsors

faculty pf medicine suez canal university
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: - age ranging from 18 to 50 years with documented uterine fibroids on pelvic imaging (pelvic ultrasound or MRI) within last 12 months, - patients complaining of abnormal vaginal bleeding, chronic pelvic pain, pressure symptoms or reproductive disorders - pre-operative hemoglobin > 8g/dl.

Exclusion criteria

Exclusion criteria: - post-menopausal women - patients previously treated with Depo-Lupron, Depo-Provera or oral contraceptive pills, - patients with known bleeding/clotting disorders, active liver, kidney or cardiovascular disease or receiving anticoagulant, NSAIDs or antiplatelet, - previous history of gynecological malignancy, - previous abdominal myomectomy or venous thromboembolism.

Design outcomes

Primary

MeasureTime frame
Studying the effect of tranexamic acid versus carbetocin on operative blood loss ( intra-and post operative ) and the needs of blood transfusion in women undergoing myomectomy.

Secondary

MeasureTime frame
the need for blood transfusion, patients hemoglobin level after the operation

Countries

Egypt

Contacts

Public Contactomima taha

suez canal university

omimatharwat@yahoo.com002001223423685

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026